Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Nov;52(11):4187-90.
doi: 10.1128/AAC.00367-08. Epub 2008 Sep 22.

Prospective study of fecal colonization by extended-spectrum-beta-lactamase-producing Escherichia coli in neutropenic patients with cancer

Affiliations

Prospective study of fecal colonization by extended-spectrum-beta-lactamase-producing Escherichia coli in neutropenic patients with cancer

L Calatayud et al. Antimicrob Agents Chemother. 2008 Nov.

Abstract

Fecal colonization by extended-spectrum-beta-lactamase-producing Escherichia coli in 912 stool samples collected from 154 neutropenic patients with cancer, hospitalized at two teaching institutions, was prospectively studied. Forty-nine (31.8%) patients were colonized, 22 of them at hospital admission. Most strains were clonally unrelated and carried a CTX-M-9 group enzyme.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Distribution of the first ESBL E. coli isolate from each of 49 fecal carriers. (a) Hospital A. (b) Hospital B. Admission*, three patients were colonized by E. coli simultaneously harboring CTX-M and OXA ESBLs.

References

    1. Bonnet, R. 2004. Growing group of extended-spectrum β-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14. - PMC - PubMed
    1. Carratalà, J., A. Fernández-Sevilla, F. Tubau, M. A. Domínguez, and F. Gudiol. 1996. Emergence of fluoroquinolone-resistant Escherichia coli in fecal flora of cancer patients receiving norfloxacin prophylaxis. Antimicrob. Agents Chemother. 40:503-505. - PMC - PubMed
    1. Clinical and Laboratory Standards Institute. 2007. Performance standards for antimicrobial susceptibility testing; 15th informational supplement. CLSI/NCCLS document M100-369 S15. Clinical and Laboratory Standards Institute, Wayne, PA.
    1. Fang, H., F. Ataker, G. Hedin, and K. Dornbusch. 2008. Molecular epidemiology of extended-spectrum β-lactamases among Escherichia coli isolates collected in a Swedish hospital and its associated health care facilities from 2001 to 2006. J. Clin. Microbiol. 46:707-712. - PMC - PubMed
    1. Hughes, W. T., D. Armstrong, G. P. Bodey, E. J. Bow, A. E. Brown, T. Calandra, R. Feld, P. A. Pizzo, K. V. Rolston, J. L. Shenep, and L. S. Young. 2002. Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin. Infect. Dis. 15:730-751. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources